Lautin E M, Freeman N J, Schoenfeld A H, Bakal C W, Haramati N, Friedman A C, Lautin J L, Braha S, Kadish E G, Sprayregen S
Department of Radiology, Monteifore Medical Center, Bronx, NY 10467.
AJR Am J Roentgenol. 1991 Jul;157(1):49-58. doi: 10.2214/ajr.157.1.2048539.
Contrast-induced nephropathy is a potentially serious untoward reaction to radiologic contrast media. The incidence of this nephropathy and the predisposing conditions are not well established, possibly because of methodologic differences between studies. We evaluated the incidence of contrast-induced nephropathy after femoral arteriography in 394 patients by using multiple definitions (different increases in serum creatinine or blood urea nitrogen levels at various times). When an increase in the level of serum creatinine of greater than 0.3 mg/dl and greater than 20% on day 1, 2, or 3 and on day 5, 6, or 7 was used to define the disorder, the incidence in our group of patients was 10% for nonazotemic patients vs 30% for azotemic patients (p less than .001); 2% for nondiabetic, nonazotemic patients vs 16% for diabetic, nonazotemic patients (p = .003); and 38% for patients who were both diabetic and azotemic vs 16% for diabetic, nonazotemic patients (p = .022). Baseline renal insufficiency and diabetes mellitus (especially when insulin dependent) were significant predisposing factors. The effects of dehydration and increased volume of contrast medium on the incidence of contrast-induced nephropathy were not clear; the age and sex of the patient were not important risk factors. The incidence of contrast-induced nephropathy depends on the definition used. Although contrast-induced nephropathy may develop in any patient, diabetes, renal insufficiency, and, possibly, dehydration and dose of contrast medium are risk factors.
对比剂肾病是对放射学造影剂的一种潜在严重不良反应。这种肾病的发病率以及诱发因素尚未完全明确,可能是由于研究之间存在方法学差异。我们通过使用多种定义(血清肌酐或血尿素氮水平在不同时间的不同升高幅度)评估了394例患者股动脉造影后对比剂肾病的发病率。当采用血清肌酐水平在第1、2或3天以及第5、6或7天升高超过0.3mg/dl且超过20%来定义该疾病时,我们的患者组中非氮质血症患者的发病率为10%,而氮质血症患者为30%(p<0.001);非糖尿病、非氮质血症患者为2%,糖尿病、非氮质血症患者为16%(p=0.003);糖尿病且氮质血症患者为38%,糖尿病、非氮质血症患者为16%(p=0.022)。基线肾功能不全和糖尿病(尤其是胰岛素依赖型)是重要的诱发因素。脱水和造影剂用量增加对对比剂肾病发病率的影响尚不清楚;患者的年龄和性别不是重要的危险因素。对比剂肾病的发病率取决于所使用的定义。虽然任何患者都可能发生对比剂肾病,但糖尿病、肾功能不全以及可能的脱水和造影剂剂量是危险因素。